S.362 - Pancreatic Cancer Research and Education Act112th Congress (2011-2012)
|Sponsor:||Sen. Whitehouse, Sheldon [D-RI] (Introduced 02/16/2011)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||02/16/2011 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.362 — 112th Congress (2011-2012)All Bill Information (Except Text)
Introduced in Senate (02/16/2011)
Pancreatic Cancer Research and Education Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to establish and implement a Pancreatic Cancer Initiative to assist in coordinating activities to address the high mortality rate associated with pancreatic cancer.
Requires the Secretary to establish the Interdisciplinary Pancreatic Cancer Coordinating Committee to: (1) provide advice on overall research objectives and benchmarks for pancreatic cancer research; (2) develop within six months of establishment of the committee and every five years thereafter a strategic plan for pancreatic cancer research awareness; and (3) conduct evaluations and make recommendations as needed to the Secretary, the Director of the National Institutes of Health (NIH), and the Director of the National Cancer Institute (NCI) regarding the prioritization and award of NIH research grants relating to pancreatic cancer.
Requires the Secretary to develop a primary care provider education program on pancreatic cancer.
Requires the Director of NCI and the Director of the Centers for Disease Control and Prevention (CDC) to develop a communication tool kit for patients and their families that focuses on specific pancreatic cancer issues relating to patient choices and patient care.
Allows the Secretary to award grants to research institutions for use in developing innovative compounds or technologies for the prevention, early detection, or treatment of those cancers with five-year survival rates of less than 50%. Requires the Secretary to focus on pancreatic cancer during the initial five fiscal years of awarding such grants.
Allows the Secretary to designate two additional Specialized Programs of Research Excellence focusing solely on pancreatic cancer research.